{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-077718","form_type":"8-K","ticker":"NWBO","cik":"0001072379","company_name":"NORTHWEST BIOTHERAPEUTICS INC","filed_at":"2024-07-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.097845+00:00","generated_at":"2026-05-31T23:26:15.436710+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.15,"calibrated_materiality_score":0.15,"confidence":"high","headline":"NWBO annual meeting re-elects directors, ratifies auditor and option awards, approves exec comp","bullets":["Re-elected Dr. Alton L. Boynton (94.04% for) and Ambassador J. Cofer Black (93.01% for) as Class I directors for three-year terms.","Ratified Cherry Bekaert LLP as independent auditor for FY2024 with 92.73% of votes cast in favor.","Ratified 2020 option awards to named executive officers (88.13% for) and non-executive directors (88.05% for).","Advisory approval of 2023 executive compensation received 87.37% of votes cast in favor."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-077718","json":"https://secwatch.observer/filing/0001104659-24-077718.json","markdown":"https://secwatch.observer/filing/0001104659-24-077718.md","text":"https://secwatch.observer/filing/0001104659-24-077718.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1072379/000110465924077718/0001104659-24-077718-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1072379/000110465924077718/tm2418878d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T23:26:15.436710+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}